Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

NCT05462314 is registered in ClinicalTrials.gov with Viome as lead sponsor.

NCT NCT05462314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Lead sponsor
Viome
Phase
Observational
Overall status
Completed
Start date
March 29, 2022
Completion date
January 21, 2025
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biliary cancer, esophageal cancer, gastric cancer, gastrointestinal cancer, liver cancer, pancreatic cancer, rectal cancer